25 related articles for article (PubMed ID: 24846918)
1. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression.
Pandya DV; Parikh RV; Gena RM; Kothari NR; Parekh PS; Chorawala MR; Jani MA; Yadav MR; Shah PA
Mol Biol Rep; 2024 Jun; 51(1):701. PubMed ID: 38822973
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of the Dab2 gene and its association with Type 2 Diabetes Mellitus in the Chinese Uyghur population.
Li YP; Adi D; Wang YH; Wang YT; Li XL; Fu ZY; Liu F; Aizezi A; Abuzhalihan J; Gai M; Ma X; Li XM; Xie X; Ma Y
PeerJ; 2023; 11():e15536. PubMed ID: 37361044
[TBL] [Abstract][Full Text] [Related]
3. si-MALAT1 attenuates thymic cancer cell proliferation and promotes apoptosis via the miR-145-5p/HMGA2 pathway.
Tan S; Chen J
Oncol Lett; 2021 Aug; 22(2):585. PubMed ID: 34122636
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-145 Inhibits Cell Migration and Invasion in Colorectal Cancer by Targeting TWIST.
Shen X; Jiang H; Chen Z; Lu B; Zhu Y; Mao J; Chai K; Chen W
Onco Targets Ther; 2019; 12():10799-10809. PubMed ID: 31849487
[TBL] [Abstract][Full Text] [Related]
5. The roles of microRNAs in the progression of castration-resistant prostate cancer.
Kojima S; Goto Y; Naya Y
J Hum Genet; 2017 Jan; 62(1):25-31. PubMed ID: 27278789
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition.
Jiang SB; He XJ; Xia YJ; Hu WJ; Luo JG; Zhang J; Tao HQ
Onco Targets Ther; 2016; 9():2305-15. PubMed ID: 27143926
[TBL] [Abstract][Full Text] [Related]
7. Disabled-2 (
Price ZK; Lokman NA; Yoshihara M; Kajiyama H; Oehler MK; Ricciardelli C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614139
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss expression of dab2 and promotor hypermethylation in human cancers: a meta-analysis and systematic review.
Zhang Z; Chen Y; Tang J; Xie X
Pak J Med Sci; 2014 Mar; 30(2):432-7. PubMed ID: 24772157
[TBL] [Abstract][Full Text] [Related]
9. [Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2].
Xie S; Xie Y; Zhang Y; Huang Q
Yi Chuan; 2014 Jan; 36(1):50-7. PubMed ID: 24846918
[TBL] [Abstract][Full Text] [Related]
10. Disabled homolog 2 is required for migration and invasion of prostate cancer cells.
Xie Y; Zhang Y; Jiang L; Zhang M; Chen Z; Liu D; Huang Q
Front Med; 2015 Sep; 9(3):312-21. PubMed ID: 26143155
[TBL] [Abstract][Full Text] [Related]
11. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
[TBL] [Abstract][Full Text] [Related]
12. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
